UNSPSC 51241245: Lithium succinate

This classification denotes an antipsychotic agent with the molecular formula C4H4O4.2LI, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MD64P82Y28. European Medicines Agency schedules lithium succinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14381MIG. The term lithium succinate is a U.S. FDA designation. As of Q4 2014, LITHIUM SUCCINATE remains the US FDA Preferred Term for this commodity. SMILES: OC(=O)CCC(=O)O.[Li].

UNSPSC 51241245 Lithium succinate, a Commodity-tier code, represents specialty chemical compounds used in medical and pharmaceutical applications. State and local governments procure under this code primarily through fire and rescue departments, health departments, and emergency medical services that stock lithium-based compounds as part of medical aid and pharmaceutical supply inventories. The scope of work encompasses the supply of lithium succinate and related pharmaceutical ingredients for emergency response and clinical settings.

The City of Tampa Fire Rescue Department issued ITB 25P00157 in April 2026, seeking medical aid supplies including a range of pharmaceutical and first aid items with an estimated annual budget of $100,000 and a response date of April 9, 2025. The solicitation included set-aside provisions for City-certified Small Local Business Enterprises (SLBEs) and Underutilized Woman and Minority Owned Business Enterprises (U-WMBEs), offering bid discounts not to exceed $10,000 for SLBEs and $20,000 for U-WMBEs. The procurement supported diversity and local economic inclusion through certification and subcontracting requirements. Activity under this code appears concentrated in Florida-based emergency services procurement, though the single recent opportunity limits characterization of broader geographic spread or repeat issuing-body patterns.